Download FREE Report Sample
Download Free sampleEpilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.
Epilepsy Drugs Market contains market size and forecasts of Epilepsy Drugs in Global, including the following market information:
Global Epilepsy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Epilepsy Drugs market was valued at 4907.2 million in 2021 and is projected to reach US$ 5939.7 million by 2028, at a CAGR of 2.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
First Generation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epilepsy Drugs include Abbott Laboratories, GlaxoSmithKline Plc, UCB, Cephalon, Johnson & Johnson, Pfizer, Novartis AG, Abbvie and Janssen Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epilepsy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epilepsy Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Epilepsy Drugs Market Segment Percentages, by Type, 2021 (%)
First Generation
Second Generation
Global Epilepsy Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Epilepsy Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Epilepsy Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Epilepsy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epilepsy Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Epilepsy Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
GlaxoSmithKline Plc
UCB
Cephalon
Johnson & Johnson
Pfizer
Novartis AG
Abbvie
Janssen Pharmaceuticals
Sunovion Pharmaceuticals
Bausch Health
Sanofi S.A
Takeda
Eisai
F. Hoffmann-La Roche
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
